(Q33737758)

English

Effects of the alpha-glucosidase inhibitor acarbose on the development of long-term complications in diabetic animals: pathophysiological and therapeutic implications

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

Effects of the alpha-glucosidase inhibitor acarbose on the development of long-term complications in diabetic animals: pathophysiological and therapeutic implications (English)

1 reference

Europe PubMed Central

29 July 2017

pathophysiology

1 reference

based on heuristic

inferred from title

author name string

Creutzfeldt W

1

1 reference

Europe PubMed Central

29 July 2017

publication date

1 July 1999

1 reference

Europe PubMed Central

29 July 2017

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

29 July 2017

15

1 reference

Europe PubMed Central

29 July 2017

289-296

1 reference

Europe PubMed Central

29 July 2017

4

1 reference

Europe PubMed Central

29 July 2017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Lessons from the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Beneficial effects of dietary acarbose in the streptozotocin-induced diabetic rat.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Alpha-glucosidase inhibition prevents increased collagen fluorescence in experimental diabetes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

The effect of chronic alpha-glycosidase inhibition on diabetic nephropathy in the db/db mouse.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Acarbose treatment and diabetic nephropathy in the Cohen diabetic rat.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Long-term suppression of postprandial hyperglycaemia with acarbose retards the development of neuropathies in the BB/W-rat

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Effect of an alpha-glycosidase inhibitor on experimentally-induced obesity in mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Beneficial effects of acarbose in the atherosclerosis-prone JCR:LA-corpulent rat.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199907%2F08%2915%3A4%3C289%3A%3AAID-DMRR48%3E3.0.CO%3B2-V

21 January 2018

Identifiers

10.1002/(SICI)1520-7560(199907/08)15:4<289::AID-DMRR48>3.0.CO;2-V

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

reason for deprecated rank

incorrect identifier value

0 references

reason for deprecated rank

incorrect identifier value

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33737758&oldid=1980226155"